LobbyingBausch Health Companies lobbying by quarter
Bausch Health Companies BHC's latest lobbying report covers Q1 2026, at $330K. The four quarters Q4 2025–Q3 2026 total $490K. Its first report covers Q2 2021; the issues it reports most are Health Issues and Budget/Appropriations.
Bausch Health CompaniesBHC
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $490K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2021
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2021 | $30K | 1 |
| Q3 2021 | $0 | 0 |
| Q4 2021 | $0 | 0 |
| Q1 2022 | $0 | 0 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $160K | 2 |
| Q1 2023 | $220K | 2 |
| Q2 2023 | $160K | 2 |
| Q3 2023 | $150K | 2 |
| Q4 2023 | $160K | 1 |
| Q1 2024 | $270K | 1 |
| Q2 2024 | $160K | 1 |
| Q3 2024 | $160K | 1 |
| Q4 2024 | $160K | 1 |
| Q1 2025 | $280K | 1 |
| Q2 2025 | $160K | 1 |
| Q3 2025 | $160K | 1 |
| Q4 2025 | $160K | 1 |
| Q1 2026 | $330K | 1 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$2.7M · 18 reports
- Budget and appropriations$65K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES18 reports
- SENATE18 reports
- Health & Human Services, Dept of (HHS)15 reports
- Federal Trade Commission (FTC)14 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseBausch Health Companies | $2.6M | 14 quarters |
| Fti Government Affairs | $130K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRIAN PAPP JR. jr | Staff Dir, Sen Fin Subcomm on Intl Trade,21,Sen Carper 21;Sr Pol Adv, Sen Carper 19-21;Leg Assist, Sen Carper 17-19;Prf Staff Mem, Comm on Hmlnd Sec & Gov Affairs 15-17;Leg Aide, Comm on Hmlnd Sec & Gov Affairs 14-15;Const Serv Rep, Sen Carper 11-14 | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 04/16for Q1 | In-house | $330K |
| 01/13for Q4 2025 | In-house | $160K |
| 25/10/02for Q3 2025 | In-house | $160K |
| 25/07/21for Q2 2025 | In-house | $160K |
| 25/04/09for Q1 2025 | In-house | $280K |
| 25/01/21for Q4 2024 | In-house | $160K |
| 24/10/21for Q3 2024 | In-house | $160K |
| 24/07/04for Q2 2024 | In-house | $160K |
| 24/04/22for Q1 2024 | In-house | $270K |
| 24/01/19for Q4 2023 | In-house | $160K |
| 24/01/17for Q3 2023 | Fti Government Affairs | Under $5,000 |
| 24/01/17for Q3 2023 | Fti Government Affairs | Under $5,000 |
| 23/10/20for Q3 2023 | Fti Government Affairs | $20K |
| 23/10/02for Q3 2023 | In-house | $150K |
| 23/07/20for Q2 2023 | Fti Government Affairs | $40K |
| 23/07/19for Q2 2023 | In-house | $120K |
| 23/04/20for Q1 2023 | Fti Government Affairs | $30K |
| 23/04/14for Q1 2023 | In-house | $190K |
| 23/02/01for Q2 2021 | Fti Government Affairs | $30K |
| 23/01/19for Q4 2022 | In-house | $130K |